{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:29:54Z","timestamp":1786987794887,"version":"build-2736575974"},"reference-count":253,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019706","name":"Qatar Biomedical Research Institute, Hamad Bin Khalifa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drudis.2026.104621","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:11:41Z","timestamp":1770397901000},"page":"104621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic targeting of FZD receptor proteins with biologics in cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Issam","family":"Hmila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-5617","authenticated-orcid":false,"given":"Vladimir L.","family":"Katanaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104621_b0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tips.2019.04.001","article-title":"GPCRomics: an approach to discover GPCR drug targets","volume":"40","author":"Insel","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0010","first-page":"1","article-title":"GCRDb: a G-protein-coupled receptor database","volume":"2","author":"Kolakowski","year":"1994","journal-title":"Recept Channels"},{"key":"10.1016\/j.drudis.2026.104621_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2004.11.014","article-title":"Trimeric G protein-dependent frizzled signaling in Drosophila","volume":"120","author":"Katanaev","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104621_b0020","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1073\/pnas.0601853103","article-title":"Dual roles for the trimeric G protein Go in asymmetric cell division in Drosophila","volume":"103","author":"Katanaev","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104621_b0025","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1242\/dev.106773","article-title":"Heterotrimeric Go protein links Wnt-Frizzled signaling with ankyrins to regulate the neuronal microtubule cytoskeleton","volume":"141","author":"Luchtenborg","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.drudis.2026.104621_b0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/bbrc.2001.5630","article-title":"Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?","volume":"287","author":"Malbon","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0035","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1060100","article-title":"G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway","volume":"292","author":"Liu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104621_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2009.2765.1","article-title":"Frizzled proteins are bona fide G protein-coupled receptors","author":"Katanaev","year":"2009","journal-title":"Nat Prec"},{"key":"10.1016\/j.drudis.2026.104621_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/BJ20101878","article-title":"Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins","volume":"433","author":"Koval","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2026.104621_b0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20150913","article-title":"Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosis","volume":"473","author":"Koval","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2026.104621_b0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/pr.110.002931","article-title":"International Union of Basic and Clinical Pharmacology. LXXX. The class Frizzled receptors","volume":"62","author":"Schulte","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.drudis.2026.104621_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104621_b0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.tcb.2016.07.009","article-title":"\u03b2-Catenin-independent roles of Wnt\/LRP6 signaling","volume":"26","author":"Acebron","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0070","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/gb-2004-5-7-234","article-title":"The Frizzled family: receptors for multiple signal transduction pathways","volume":"5","author":"Huang","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0080","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06554","article-title":"Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5\/6, and proteoglycan","volume":"4","author":"Chang","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104621_b0085","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1038\/s41467-024-51664-4","article-title":"Structural basis of frizzled 7 activation and allosteric regulation","volume":"15","author":"Bous","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1599355","article-title":"Frizzled receptors: gatekeepers of Wnt signaling in development and disease","volume":"13","author":"Martinez-Marin","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0095","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S1097-2765(03)00427-1","article-title":"Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled","volume":"12","author":"Wong","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2026.104621_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abo4974","article-title":"WNT stimulation induces dynamic conformational changes in the Frizzled-Dishevelled interaction","volume":"16","author":"Bowin","year":"2023","journal-title":"Sci Signal"},{"key":"10.1016\/j.drudis.2026.104621_b0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/dvdy.22060","article-title":"The trimeric G protein Go inflicts a double impact on axin in the Wnt\/frizzled signaling pathway","volume":"239","author":"Egger-Adam","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1016\/j.drudis.2026.104621_b0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature04185","article-title":"A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation","volume":"438","author":"Zeng","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104621_b0115","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1101\/gad.1424006","article-title":"Wnt signaling: is the party in the nucleus?","volume":"20","author":"Willert","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2026.104621_b0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev-cellbio-100814-125315","article-title":"Wnt-Frizzled\/planar cell polarity signaling: cellular orientation by facing the wind (Wnt)","volume":"31","author":"Yang","year":"2015","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/abbs\/gmr079","article-title":"Wnt\/Ca2+ signaling pathway: a brief overview","volume":"43","author":"De","year":"2011","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.drudis.2026.104621_b0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ceca.2005.06.022","article-title":"Wnt and calcium signaling: beta-catenin-independent pathways","volume":"38","author":"Kohn","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2026.104621_b0135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.drudis.2012.07.007","article-title":"Platforms for high-throughput screening of Wnt\/Frizzled antagonists","volume":"17","author":"Koval","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104621_b0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104621_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2052-8426-2-28","article-title":"Targeting the Wnt pathways for therapies","volume":"2","author":"Blagodatski","year":"2014","journal-title":"Mol Cell Ther"},{"key":"10.1016\/j.drudis.2026.104621_b0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","article-title":"Mutations and mechanisms of WNT pathway tumour suppressors in cancer","volume":"21","author":"Bugter","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104621_b0155","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-18-2757","article-title":"Wnt\/PCP signaling contribution to carcinoma collective cell migration and metastasis","volume":"79","author":"VanderVorst","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/mol.119.117978","article-title":"Wnt signaling and drug resistance in cancer","volume":"97","author":"Zhong","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b0165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molmed.2023.03.006","article-title":"Cells of the tumor microenvironment speak the Wnt language","volume":"29","author":"Katanaev","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2026.104621_b0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11912-019-0763-9","article-title":"Recent development of Wnt signaling pathway inhibitors for cancer therapeutics","volume":"21","author":"Harb","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.mcb.2018.08.006","article-title":"A high-throughput assay pipeline for specific targeting of frizzled GPCRs in cancer","volume":"149","author":"Shaw","year":"2019","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0180","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20129","article-title":"Targeting the Wnt signalling pathway in cancer: prospects and perils","volume":"149","author":"Shaw","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.drudis.2026.104621_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115539","article-title":"Clofazimine: a journey of a drug","volume":"167","author":"Xu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104621_b0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/cancers8070066","article-title":"A second WNT for old drugs: drug repositioning against WNT-dependent cancers","volume":"8","author":"Ahmed","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104621_b0195","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1021\/acsptsci.4c00570","article-title":"Challenging reported Frizzled-targeting compounds in selective assays reveals lack of functional inhibition and claimed profiles","volume":"7","author":"Koval","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0200","doi-asserted-by":"crossref","first-page":"22332","DOI":"10.1021\/acs.jmedchem.4c02766","article-title":"A putative Frizzled 7-targeting compound acts as a firefly luciferase inhibitor","volume":"67","author":"Kinsolving","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104621_b0205","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1038\/sj.onc.1202985","article-title":"Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response","volume":"18","author":"Gazit","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104621_b0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1095\/biolreprod.112.102608","article-title":"FZD1 regulates cumulus expansion genes and is required for normal female fertility in mice","volume":"87","author":"Lapointe","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.drudis.2026.104621_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115720","article-title":"The Wnt\/\u03b2-catenin pathway is involved in 2,5-hexanedione-induced ovarian granulosa cell cycle arrest","volume":"268","author":"Xu","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.drudis.2026.104621_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1302488","article-title":"Spatial gene expression profile of Wnt-signaling components in the murine enteric nervous system","volume":"15","author":"Scharr","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104621_b0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/0008-5472.CAN-20-2876","article-title":"Hypoxia-induced suppression of alternative splicing of MBD2 promotes breast cancer metastasis via activation of FZD1","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0230","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/s41380-022-01492-z","article-title":"Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters","volume":"27","author":"Palomer","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.drudis.2026.104621_b0235","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104621_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1054614","article-title":"Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma","volume":"9","author":"Huang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2026.104621_b0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12920-023-01450-w","article-title":"FZD1\/KLF10-hsa-miR-4762-5p\/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report","volume":"16","author":"Jia","year":"2023","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.drudis.2026.104621_b0250","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/onc.2009.80","article-title":"The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/beta-catenin pathway","volume":"28","author":"Flahaut","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104621_b0255","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1080\/21655979.2021.2005218","article-title":"Protein disulfide isomerase family 6 promotes the imatinib-resistance of renal cell carcinoma by regulation of Wnt3a-Frizzled1 axis","volume":"12","author":"Huang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.drudis.2026.104621_b0260","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/CAD.0000000000000236","article-title":"Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes","volume":"26","author":"Zhang","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.drudis.2026.104621_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105078","article-title":"An integrative pan-cancer analysis of the molecular characteristics of dietary restriction in tumour microenvironment","volume":"102","author":"Song","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2026.104621_b0270","article-title":"LINC00942 promotes tumor proliferation and metastasis in lung adenocarcinoma via FZD1 upregulation","volume":"20","author":"Wang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.drudis.2026.104621_b0275","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jare.2024.07.022","article-title":"A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to \u03b2-catenin and suppressing the Wnt signaling pathway","volume":"72","author":"Yang","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.drudis.2026.104621_b0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12032-022-01877-8","article-title":"Molecular characterization of early breast cancer onset to understand disease phenotypes in African patients","volume":"40","author":"Tonouo","year":"2022","journal-title":"Med Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0285","doi-asserted-by":"crossref","first-page":"12444","DOI":"10.1073\/pnas.1406639111","article-title":"Wnt ligand\/Frizzled 2 receptor signaling regulates tube shape and branch-point formation in the lung through control of epithelial cell shape","volume":"111","author":"Kadzik","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104621_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2024.102391","article-title":"Selective activation of FZD2 and FZD7 reveals non-redundant function during mesoderm differentiation","volume":"20","author":"Chidiac","year":"2025","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0295","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/hmg\/ddv088","article-title":"A mutation in FRIZZLED2 impairs Wnt signaling and causes autosomal dominant omodysplasia","volume":"24","author":"Saal","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2026.104621_b0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10565-024-09956-4","article-title":"Investigating the role of Wnt3a and Wnt5a as critical factors of hepatic stellate cell activation in acute toxicant-induced liver injury","volume":"41","author":"Rutt","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.drudis.2026.104621_b0305","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2014.10.032","article-title":"A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis","volume":"159","author":"Gujral","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104621_b0310","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/or.2016.4885","article-title":"Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer","volume":"36","author":"Bian","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0315","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3892\/or.2015.4285","article-title":"Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway","volume":"34","author":"Zhang","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0320","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/etm.2024.12662","article-title":"Interference of FZD2 suppresses proliferation, vasculogenic mimicry and stemness in glioma cells via blocking the Notch\/NF\u2011\u03baB signaling pathway","volume":"28","author":"Ran","year":"2024","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.drudis.2026.104621_b0325","doi-asserted-by":"crossref","first-page":"46187","DOI":"10.18632\/oncotarget.10070","article-title":"Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with \u03b2-catenin-dependent and \u03b2-catenin-independent signaling pathways","volume":"7","author":"Zins","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104621_b0330","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1242\/dev.083352","article-title":"Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes","volume":"139","author":"Yu","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.drudis.2026.104621_b0335","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.258864","article-title":"Frizzled3 inhibits Vangl2-Prickle3 association to establish planar cell polarity in the vertebrate neural plate","volume":"134","author":"Chuykin","year":"2021","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0340","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1523\/JNEUROSCI.1840-15.2015","article-title":"Frizzled3 controls axonal polarity and intermediate target entry during striatal pathway development","volume":"35","author":"Morello","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2026.104621_b0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01482","article-title":"Frizzled3 controls axonal development in distinct populations of cranial and spinal motor neurons","volume":"2","author":"Hua","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104621_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109947","article-title":"Non-canonical Wnt pathway expression in the developing mouse and human retina","volume":"244","author":"Campos","year":"2024","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.drudis.2026.104621_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.779871","article-title":"Fzd3 expression within inner ear afferent neurons is necessary for central pathfinding","volume":"15","author":"Stoner","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2026.104621_b0360","first-page":"23233","article-title":"NEAT1 regulates microtubule stabilization via FZD3\/GSK3\u03b2\/P-tau pathway in SH-SY5Y cells and APP\/PS1 mice","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.drudis.2026.104621_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110946","article-title":"The involvement of noncanonical Wnt signaling in cancers","volume":"133","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104621_b0370","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pbio.0040115","article-title":"Purified Wnt5a protein activates or inhibits \u03b2-catenin\u2013TCF signaling depending on receptor context","volume":"4","author":"Mikels","year":"2006","journal-title":"PLoS Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/emboj.2009.322","article-title":"Wnt5a regulates distinct signalling pathways by binding to Frizzled2","volume":"29","author":"Sato","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2026.104621_b0380","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1098\/rstb.2007.2255","article-title":"Calcium dynamics integrated into signalling pathways that influence vertebrate axial patterning","volume":"363","author":"Freisinger","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0385","first-page":"677","article-title":"MicroRNA-186-5p inhibits the metastasis of cervical cancer by targeting FZD3","volume":"26","author":"Wang","year":"2021","journal-title":"J BUON"},{"key":"10.1016\/j.drudis.2026.104621_b0390","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s43141-023-00532-7","article-title":"In silico analysis reveals mir-98-5p as a potential inhibitor of tumor cell proliferation and metastasis in colorectal cancer by targeting the fzd3 receptor of the Wnt signaling pathway","volume":"21","author":"Kenneth","year":"2023","journal-title":"J Genet Eng Biotechnol"},{"key":"10.1016\/j.drudis.2026.104621_b0395","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5114\/pjp.2022.117179","article-title":"LncRNA FGD5-AS1 drives the malignant development of gastric cancer by negatively interacting with FZD3","volume":"73","author":"Feng","year":"2022","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.drudis.2026.104621_b0400","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/MCB.01780-07","article-title":"Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism","volume":"28","author":"Endo","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0405","doi-asserted-by":"crossref","first-page":"27533","DOI":"10.1074\/jbc.M109.048884","article-title":"Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner","volume":"284","author":"Hansen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104621_b0410","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/1120009X.2023.2182573","article-title":"Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt\/\u03b2-catenin signaling pathway inhibition in hepatocellular carcinoma cells","volume":"35","author":"Meng","year":"2023","journal-title":"J Chemother"},{"key":"10.1016\/j.drudis.2026.104621_b0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/1120009X.2023.2219920","article-title":"Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin","volume":"36","author":"Zhu","year":"2024","journal-title":"J Chemother"},{"key":"10.1016\/j.drudis.2026.104621_b0420","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","article-title":"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair","volume":"116","author":"Xu","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104621_b0425","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1038\/s41467-023-37689-1","article-title":"Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD(4)-selective WNT surrogate in mice","volume":"14","author":"Ding","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.121400","article-title":"Cadmium aggravates the blood-brain barrier disruption via inhibition of the Wnt7A\/\u03b2-catenin signaling axis","volume":"324","author":"Li","year":"2023","journal-title":"Environ Pollut"},{"key":"10.1016\/j.drudis.2026.104621_b0435","first-page":"1215","article-title":"Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4","volume":"33","author":"Tickenbrock","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0440","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/0008-5472.CAN-10-0244","article-title":"FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"70","author":"Gupta","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0445","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/0008-5472.CAN-10-1495","article-title":"Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0450","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/1535-7163.MCT-11-0592","article-title":"Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4","volume":"11","author":"Ueno","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2026.104621_b0455","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.biopha.2017.04.028","article-title":"MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4","volume":"92","author":"Ma","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104621_b0460","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000082277","article-title":"Wnt\/frizzled signaling during vertebrate retinal development","volume":"26","author":"Van Raay","year":"2004","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.drudis.2026.104621_b0465","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00439-024-02712-y","article-title":"Homozygosity for a hypomorphic mutation in frizzled class receptor 5 causes syndromic ocular coloboma with microcornea in humans","volume":"143","author":"Cort\u00e9s-Gonz\u00e1lez","year":"2024","journal-title":"Hum Genet"},{"key":"10.1016\/j.drudis.2026.104621_b0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dev.128.1.25","article-title":"Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis","volume":"128","author":"Ishikawa","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.drudis.2026.104621_b0475","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10456-017-9574-5","article-title":"Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis","volume":"20","author":"Peterson","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.drudis.2026.104621_b0480","doi-asserted-by":"crossref","DOI":"10.1242\/dev.202545","article-title":"Exploiting spatiotemporal regulation of FZD5 during neural patterning for efficient ventral midbrain specification","volume":"151","author":"Yang","year":"2024","journal-title":"Development"},{"key":"10.1016\/j.drudis.2026.104621_b0485","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1007\/s13277-015-3369-3","article-title":"miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma","volume":"36","author":"Long","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12964-024-01585-y","article-title":"Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1","volume":"22","author":"Xia","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2026.104621_b0495","doi-asserted-by":"crossref","first-page":"49130","DOI":"10.18632\/oncotarget.9734","article-title":"MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104621_b0500","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2326-6066.CIR-24-0484","article-title":"Blocking WNT7A enhances MHC-I antigen presentation and enhances the effectiveness of immune checkpoint blockade therapy","volume":"13","author":"Sun","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.drudis.2026.104621_b0505","article-title":"DNMT3A-mediated DNA methylation and transcription inhibition of FZD5 suppresses lung carcinogenesis","volume":"10","author":"Shen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.drudis.2026.104621_b0510","article-title":"Insilco prediction of the role of the FriZZled5 gene in colorectal cancer","volume":"36","author":"Hosseini-Abgir","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0515","article-title":"Aberrant cholesterol metabolism and Wnt\/\u03b2-catenin signaling coalesce via Frizzled5 in supporting cancer growth","volume":"9","author":"Zheng","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104621_b0520","doi-asserted-by":"crossref","first-page":"e2453","DOI":"10.1002\/bdr2.2453","article-title":"Functional evaluation of neural tube defect-related missense mutations using in silico methods","volume":"117","author":"Biterge","year":"2025","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.drudis.2026.104621_b0525","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/jid.2013.84","article-title":"Frizzled6 deficiency disrupts the differentiation process of nail development","volume":"133","author":"Cui","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2026.104621_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175996","article-title":"Frizzled 6 mutation regulates reserpine-induced depression-like behavior and Wnt signaling pathway in mice","volume":"957","author":"Yan","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b0535","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2024.12.011","article-title":"Effects of Fzd6 on intestinal flora and neuroinflammation in lipopolysaccharide-induced depression-like mice","volume":"372","author":"Chen","year":"2025","journal-title":"J Affect Disord"},{"key":"10.1016\/j.drudis.2026.104621_b0540","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92645","article-title":"Inhibition of miR-199b-5p reduces pathological alterations in osteoarthritis by potentially targeting Fzd6 and Gcnt2","volume":"12","author":"Feng","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104621_b0545","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/mc.23789","article-title":"Frizzled 6 endows high-grade serous ovarian cancer with stem-like properties and chemoresistance","volume":"63","author":"Chen","year":"2024","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.drudis.2026.104621_b0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12929-024-01057-y","article-title":"Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression","volume":"31","author":"Panda","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.783735","article-title":"The prognostic value of the developmental gene FZD6 in young Saudi breast cancer patients: a biomarkers discovery and cancer inducers oncoScreen approach","volume":"9","author":"Assidi","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2026.104621_b0560","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.4841","article-title":"Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer","volume":"241","author":"Corda","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.drudis.2026.104621_b0565","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.drudis.2021.12.008","article-title":"Unlocking the Wnt pathway: therapeutic potential of selective targeting FZD(7) in cancer","volume":"27","author":"Larasati","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104621_b0570","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.bjc.6605307","article-title":"Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells","volume":"101","author":"Ueno","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.drudis.2026.104621_b0575","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2017.05.024","article-title":"RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a\/Fzd7-driven noncanonical Wnt pathway","volume":"402","author":"Dong","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104621_b0580","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35083601","article-title":"Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains","volume":"412","author":"Dann","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104621_b0585","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-008-9156-4","article-title":"The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression","volume":"25","author":"Vincan","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.drudis.2026.104621_b0590","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1593\/neo.08320","article-title":"Frizzled-7 as a potential therapeutic target in colorectal cancer","volume":"10","author":"Ueno","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.drudis.2026.104621_b0595","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jhep.2007.12.020","article-title":"Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt\/beta-catenin signaling pathway in hepatocellular carcinoma cells","volume":"48","author":"Kim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.drudis.2026.104621_b0600","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1053\/j.gastro.2004.07.009","article-title":"Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma","volume":"127","author":"Merle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2026.104621_b0605","first-page":"7693","article-title":"Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-\u03baB","volume":"15","author":"Xue","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.drudis.2026.104621_b0610","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ph14010028","article-title":"Immunotherapy and targeted therapy for hepatocellular carcinoma: a literature review and treatment perspectives","volume":"14","author":"Girardi","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2026.104621_b0615","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2010.06.033","article-title":"Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma","volume":"54","author":"Nambotin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.drudis.2026.104621_b0620","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1038\/onc.2011.145","article-title":"FZD7 has a critical role in cell proliferation in triple negative breast cancer","volume":"30","author":"Yang","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104621_b0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098861","article-title":"Frizzled 7 expression is positively regulated by SIRT1 and \u03b2-catenin in breast cancer cells","volume":"9","author":"Simmons","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104621_b0630","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12964-020-00646-2","article-title":"Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1","volume":"18","author":"Yin","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2026.104621_b0635","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3040","article-title":"\u0394Np63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling","volume":"16","author":"Chakrabarti","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0640","doi-asserted-by":"crossref","first-page":"14323","DOI":"10.1021\/acsomega.3c10275","article-title":"FZD7-targeted nanoparticles to enhance doxorubicin treatment of triple-negative breast cancer","volume":"9","author":"Hoover","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2026.104621_b0645","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13046-024-03083-y","article-title":"Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer","volume":"43","author":"Atwani","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0650","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/0008-5472.CAN-20-1488","article-title":"Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0655","doi-asserted-by":"crossref","first-page":"e1346","DOI":"10.1038\/cddis.2014.302","article-title":"FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt\/PCP pathway","volume":"5","author":"Asad","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104621_b0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147638","article-title":"FRIZZLED7 is required for tumor initiation and metastatic growth of melanoma cells","volume":"11","author":"Tiwary","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104621_b0665","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3892\/mmr.2020.11690","article-title":"Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0670","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/cam4.3819","article-title":"Fzd7\/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.drudis.2026.104621_b0675","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12032-015-0552-8","article-title":"Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines","volume":"32","author":"Deng","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0680","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s12013-024-01656-4","article-title":"Silencing of FZD7 inhibits endometriotic cell viability, migration, and angiogenesis by promoting ferroptosis","volume":"83","author":"Zhang","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.drudis.2026.104621_b0685","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/onc.2010.549","article-title":"Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target","volume":"30","author":"Pode-Shakked","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104621_b0690","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.18632\/oncotarget.6742","article-title":"FZD7 regulates BMSCs-mediated protection of CML cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104621_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216280","article-title":"A complex of Wnt\/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties","volume":"567","author":"Dreyer","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104621_b0700","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/cas.15721","article-title":"Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt\/\u03b2-catenin signaling","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0705","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/865463","article-title":"Evidence for bladder urothelial pathophysiology in functional bladder disorders","volume":"2014","author":"Keay","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2026.104621_b0710","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4111\/icu.2018.59.4.257","article-title":"Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: a rat model","volume":"59","author":"Mahal","year":"2018","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.drudis.2026.104621_b0715","article-title":"Mendelian disorders in an interstitial cystitis\/bladder pain syndrome cohort","volume":"4","author":"Estrella","year":"2023","journal-title":"Adv Genet (Hoboken)"},{"key":"10.1016\/j.drudis.2026.104621_b0720","article-title":"Single-cell transcriptome identifies drug-resistance signature and immunosuppressive microenvironment in metastatic small cell lung cancer","volume":"3","author":"Zhang","year":"2022","journal-title":"Adv Genet (Hoboken)"},{"key":"10.1016\/j.drudis.2026.104621_b0725","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2011.11.055","article-title":"Frizzled-8 as a putative therapeutic target in human lung cancer","volume":"417","author":"Wang","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0730","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2147\/OTT.S100633","article-title":"Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt\/\u03b2-catenin signaling pathway","volume":"9","author":"Fu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.drudis.2026.104621_b0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18632\/genesandcancer.204","article-title":"Novel strategies to target chemoresistant triple-negative breast cancer","volume":"11","author":"Venkatesh","year":"2020","journal-title":"Genes Cancer"},{"key":"10.1016\/j.drudis.2026.104621_b0740","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1515\/med-2022-0490","article-title":"Overexpression of miR-100-5p inhibits papillary thyroid cancer progression via targeting FZD8","volume":"17","author":"Ma","year":"2022","journal-title":"Open Med (Wars)"},{"key":"10.1016\/j.drudis.2026.104621_b0745","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1158\/0008-5472.CAN-14-0826","article-title":"Targeting the c-Met\/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas","volume":"74","author":"Sun","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0750","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s43046-024-00206-6","article-title":"CircMCTP2 enhances the progression of bladder cancer by regulating the miR-99a-5p\/FZD8 axis","volume":"36","author":"Liu","year":"2024","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1016\/j.drudis.2026.104621_b0755","first-page":"13","article-title":"FZD8 indicates a poor prognosis and promotes gastric cancer invasion and metastasis via B-catenin signaling pathway","volume":"50","author":"Chen","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0760","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.cell.2015.10.041","article-title":"K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104621_b0765","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood-2004-06-2334","article-title":"Frizzled 9 knock-out mice have abnormal B-cell development","volume":"105","author":"Ranheim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2026.104621_b0770","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1242\/dev.01871","article-title":"Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval","volume":"132","author":"Zhao","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.drudis.2026.104621_b0775","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fnmol.2019.00184","article-title":"Frizzled-9+ supporting cells are progenitors for the generation of hair cells in the postnatal mouse cochlea","volume":"12","author":"Zhang","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2026.104621_b0780","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300977R","article-title":"Frizzled-9 triggers actin polymerization and activates mechano-transducer YAP to rescue simulated microgravity-induced osteoblast dysfunction","volume":"37","author":"Shi","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104621_b0785","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12920-022-01227-7","article-title":"Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders","volume":"15","author":"Zhou","year":"2022","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.drudis.2026.104621_b0790","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41598-018-37715-z","article-title":"The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease","volume":"9","author":"Majer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0795","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2006.00770.x","article-title":"Upregulation of frizzled 9 in astrocytomas","volume":"32","author":"Zhang","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.drudis.2026.104621_b0800","first-page":"861","article-title":"SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells","volume":"35","author":"Fujimoto","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0805","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1593\/neo.91690","article-title":"Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1","volume":"12","author":"Tennis","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.drudis.2026.104621_b0810","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900490","article-title":"The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets","volume":"4","author":"Zacar\u00edas-Fluck","year":"2021","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.drudis.2026.104621_b0815","article-title":"Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104621_b0820","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4274\/ejbh.2020.5804","article-title":"An in silico analysis identified FZD9 as a potential prognostic biomarker in triple-negative breast cancer patients","volume":"17","author":"de Bastos","year":"2021","journal-title":"Eur J Breast Health"},{"key":"10.1016\/j.drudis.2026.104621_b0825","doi-asserted-by":"crossref","first-page":"19625","DOI":"10.1074\/jbc.M409392200","article-title":"Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation","volume":"280","author":"Winn","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104621_b0830","doi-asserted-by":"crossref","first-page":"26943","DOI":"10.1074\/jbc.M604145200","article-title":"Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma","volume":"281","author":"Winn","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104621_b0835","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.815737","article-title":"Loss of Frizzled 9 in lung cells alters epithelial phenotype and promotes premalignant lesion development","volume":"12","author":"Sompel","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0840","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12964-025-02039-9","article-title":"Wnt signalling facilitates neuronal differentiation of cochlear Frizzled10-positive cells in mouse cochlea via glypican 6 modulation","volume":"23","author":"Wang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.drudis.2026.104621_b0845","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cellsig.2017.01.023","article-title":"FZD10\u2013G\u03b113 signalling axis points to a role of FZD10 in CNS angiogenesis","volume":"32","author":"Hot","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.drudis.2026.104621_b0850","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1038\/sj.onc.1208780","article-title":"Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas","volume":"24","author":"Nagayama","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104621_b0855","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1084713","article-title":"Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrence","volume":"12","author":"Tulalamba","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0860","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1038\/s41598-024-82967-7","article-title":"Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation","volume":"14","author":"Ngernsombat","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104621_b0865","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","article-title":"N6-Methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells' properties and lenvatinib resistance through WNT\/\u03b2-catenin and Hippo signaling pathways","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2026.104621_b0870","doi-asserted-by":"crossref","first-page":"824","DOI":"10.18632\/oncotarget.23159","article-title":"Frizzled-10 and cancer progression: is it a new prognostic marker?","volume":"9","author":"Scavo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104621_b0875","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1038\/ncomms6406","article-title":"BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10","volume":"5","author":"Gong","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b0880","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cas.15235","article-title":"FZD10-targeted \u03b1-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model","volume":"113","author":"Sudo","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0885","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/cas.13636","article-title":"\u03b1-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0890","first-page":"1351","article-title":"Exosomal FZD10 derived from non-small cell lung cancer cells promotes angiogenesis of human umbilical venous endothelial cells in vitro","volume":"42","author":"Wu","year":"2022","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.drudis.2026.104621_b0895","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cells8080777","article-title":"FZD10 carried by exosomes sustains cancer cell proliferation","volume":"8","author":"Scavo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104621_b0900","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.3390\/ijms21186705","article-title":"A possible role of FZD10 delivering exosomes derived from colon cancers cell lines in inducing activation of epithelial-mesenchymal transition in normal colon epithelial cell line","volume":"21","author":"Scavo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0905","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2715968","article-title":"Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer","volume":"2019","author":"Scavo","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0910","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.730093","article-title":"Exosome released FZD10 increases Ki-67 expression via phospho-ERK1\/2 in colorectal and gastric cancer","volume":"11","author":"Scavo","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b0915","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1073\/pnas.1120068109","article-title":"Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors","volume":"109","author":"Gurney","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104621_b0920","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2019.02.018","article-title":"Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor","volume":"449","author":"Ahmed","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104621_b0925","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.str.2022.11.009","article-title":"An epitope-directed selection strategy facilitating the identification of Frizzled receptor selective antibodies","volume":"31","author":"Ge","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.drudis.2026.104621_b0930","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/19420862.2018.1515565","article-title":"A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties","volume":"10","author":"Pavlovic","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.drudis.2026.104621_b0935","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nm.4219","article-title":"Genome-wide CRISPR screens reveal a Wnt\u2013FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors","volume":"23","author":"Steinhart","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104621_b0940","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/21655979.2016.1255383","article-title":"Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor","volume":"8","author":"Nickho","year":"2017","journal-title":"Bioengineered"},{"key":"10.1016\/j.drudis.2026.104621_b0945","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-017-4641-6","article-title":"Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes","volume":"169","author":"Zarei","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.drudis.2026.104621_b0950","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-020-01800-x","article-title":"A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt\/\u03b2-catenin signaling pathway","volume":"40","author":"Xie","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127846","article-title":"Identification and functional validation of FZD8-specific antibodies","volume":"254","author":"Li","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2026.104621_b0960","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1349-7006.2007.00701.x","article-title":"Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10","volume":"99","author":"Fukukawa","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104621_b0965","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1073\/pnas.1817246116","article-title":"Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies","volume":"116","author":"Raman","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104621_b0970","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41589-018-0035-2","article-title":"A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells","volume":"14","author":"Nile","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.08.005","article-title":"Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28","volume":"146","author":"Le","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104621_b0980","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-17-2157","article-title":"A first-in-human Phase I study of the anticancer stem cell agent ipafricept (OMP-54F28), a decoy receptor for Wnt ligands, in patients with advanced solid tumors","volume":"23","author":"Jimeno","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104621_b0985","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-10-16","article-title":"Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin","volume":"10","author":"Wei","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1016\/j.drudis.2026.104621_b0990","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41594-019-0224-z","article-title":"Receptor subtype discrimination using extensive shape complementary designed interfaces","volume":"26","author":"Dang","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2026.104621_b0995","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104621_b1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101425","article-title":"Nanobodies in cancer","volume":"52","author":"Verhaar","year":"2021","journal-title":"Semin Immunol"},{"key":"10.1016\/j.drudis.2026.104621_b1005","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s40265-018-0989-0","article-title":"Caplacizumab: first global approval","volume":"78","author":"Duggan","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2026.104621_b1010","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","article-title":"NANOBODIES\u00ae: a review of diagnostic and therapeutic applications","volume":"24","author":"Jin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104621_b1015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pharmtox-010716-104710","article-title":"Nanobodies to study G protein-coupled receptor structure and function","volume":"57","author":"Manglik","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2026.104621_b1020","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1038\/s41467-024-51451-1","article-title":"Structural insights into Frizzled3 through nanobody modulators","volume":"15","author":"Hillier","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/19420862.2015.989023","article-title":"Functional inhibition of \u03b2-catenin-mediatedWnt signaling by intracellular VHH antibodies","volume":"7","author":"Newnham","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.drudis.2026.104621_b1030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1074\/mcp.M114.044016","article-title":"Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells","volume":"14","author":"Traenkle","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2026.104621_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115708","article-title":"Modulation of cell physiology by bispecific nanobodies enabling changes in the intracellular localization of organelle proteins","volume":"215","author":"Tsuruta","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b1040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41467-018-08172-z","article-title":"Anti-LRP5\/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells","volume":"10","author":"Fenderico","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2025.110922","article-title":"Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2","author":"Guo","year":"2025","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.drudis.2026.104621_b1050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.114.094821","article-title":"Potent and efficacious inhibition of CXCR2 signaling by biparatopic nanobodies combining two distinct modes of action","volume":"87","author":"Bradley","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b1055","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-020-15884-8","article-title":"Improved GPCR ligands from nanobody tethering","volume":"11","author":"Cheloha","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1060","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41467-024-49068-5","article-title":"Highly biased agonism for GPCR ligands via nanobody tethering","volume":"15","author":"Sachdev","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1065","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104621_b1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149401","article-title":"Nanobodies as negative allosteric modulators for human calcium sensing receptor","volume":"695","author":"Cui","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sbi.2011.06.011","article-title":"Nanobody stabilization of G protein-coupled receptor conformational states","volume":"21","author":"Steyaert","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2026.104621_b1080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the \u03b22 adrenergic receptor\u2013Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104621_b1085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/mol.113.089516","article-title":"Regulation of \u03b22-adrenergic receptor function by conformationally selective single-domain intrabodies","volume":"85","author":"Staus","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b1090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104621_b1095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2018.09.011","article-title":"Aptamer-guided nanomedicines for anticancer drug delivery","volume":"134","author":"Alshaer","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2026.104621_b1100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-024-03295-4","article-title":"Aptamers as an approach to targeted cancer therapy","volume":"24","author":"Mahmoudian","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.drudis.2026.104621_b1105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104621_b1110","series-title":"Aptamers for Food Applications","first-page":"29","article-title":"Aptamer and its selection via various SELEX strategies","author":"Yang","year":"2023"},{"key":"10.1016\/j.drudis.2026.104621_b1115","doi-asserted-by":"crossref","first-page":"13446","DOI":"10.18632\/oncotarget.7178","article-title":"Aptamers: a promising chemical antibody for cancer therapy","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104621_b1120","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/cells11111825","article-title":"Nucleic acid aptamers emerging as modulators of G-protein-coupled receptors: challenge to difficult cell surface proteins","volume":"11","author":"Takahashi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104621_b1125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbrc.2004.12.011","article-title":"An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein","volume":"327","author":"Lee","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2005.02.119","article-title":"Inhibition of the DNA binding by the TCF-1 binding RNA aptamer","volume":"330","author":"Park","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2026.104621_b1135","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1158\/1535-7163.MCT-05-0204","article-title":"Intracellular expression of the T-cell factor-1 RNA aptamer as an intramer","volume":"5","author":"Choi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2026.104621_b1140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-59745-561-9_20","article-title":"Use of RNA aptamers for the modulation of cancer cell signaling","volume":"542","author":"Jeong","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.drudis.2026.104621_b1145","article-title":"Negative regulation of Wnt\/\u03b2-catenin signaling is blocked by Wnt signaling component protein Dishevelled1 binding aptamer (WD-Aptamer)","volume":"5","author":"Choi","year":"2020","journal-title":"Clin Dermatol J"},{"key":"10.1016\/j.drudis.2026.104621_b1150","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.3390\/molecules28093838","article-title":"Screening and identification of ssDNA aptamers for low-density lipoprotein (LDL) receptor-related protein 6","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104621_b1155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093441","article-title":"Targeted disruption of \u03b2-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth","volume":"9","author":"Kotula","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104621_b1160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/abio.2002.5663","article-title":"Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1","volume":"305","author":"Daniels","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.drudis.2026.104621_b1165","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1128\/JVI.00451-12","article-title":"TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core","volume":"86","author":"Valle-Casuso","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2026.104621_b1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173104","article-title":"A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis","volume":"878","author":"Suzuki","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104621_b1175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2026.104621_b1180","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/biom15060818","article-title":"Advancements in SELEX technology for aptamers and emerging applications in therapeutics and drug delivery","volume":"15","author":"Feng","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104621_b1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124998","article-title":"Recent progress of SELEX methods for screening nucleic acid aptamers","volume":"266","author":"Zhu","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.drudis.2026.104621_b1190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2023.03.008","article-title":"Modulation of Wnt-\u03b2-catenin signaling with antibodies: therapeutic opportunities and challenges","volume":"44","author":"O'Brien","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2026.104621_b1195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-020-05817-w","article-title":"Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer","volume":"184","author":"Diamond","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.drudis.2026.104621_b1200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2019.04.001","article-title":"A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer","volume":"154","author":"Moore","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.drudis.2026.104621_b1205","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","article-title":"Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance","volume":"60","author":"Thurber","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2026.104621_b1210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2005.01.001","article-title":"Immunogenicity of engineered antibodies","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.drudis.2026.104621_b1215","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/pharmaceutics17050550","article-title":"A review on the stability challenges of advanced biologic therapeutics","volume":"17","author":"Sarvepalli","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2026.104621_b1220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632687","article-title":"Immunogenicity risk profile of nanobodies","volume":"12","author":"Ackaert","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104621_b1225","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1111\/febs.15809","article-title":"Immunogenicity and humanization of single-domain antibodies","volume":"289","author":"Rossotti","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.drudis.2026.104621_b1230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2018.10.008","article-title":"Pharmacokinetics, pharmacodynamics and safety of aptamers","volume":"134","author":"Kovacevic","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2026.104621_b1235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104621_b1240","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2528902","article-title":"Artificial intelligence-driven computational methods for antibody design and optimization","volume":"17","author":"Vecchietti","year":"2025","journal-title":"MAbs"},{"key":"10.1016\/j.drudis.2026.104621_b1245","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00343","article-title":"AIoptamer: artificial intelligence-driven aptamer optimization pipeline for targeted therapeutics in healthcare","volume":"22","author":"Gupta","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.drudis.2026.104621_b1250","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10637-019-00824-1","article-title":"A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer","volume":"38","author":"Davis","year":"2020","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.drudis.2026.104621_b1255","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1641137","article-title":"A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth","volume":"13","author":"Vax","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.drudis.2026.104621_b1260","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1117-1384d","article-title":"Corrigendum: Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors","volume":"23","author":"Steinhart","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104621_b1265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46134","article-title":"Tailored tetravalent antibodies potently and specifically activate Wnt\/Frizzled pathways in cells, organoids and mice","volume":"8","author":"Tao","year":"2019","journal-title":"Elife"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:07:49Z","timestamp":1773421669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":253,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1359644626000267"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104621","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of FZD receptor proteins with biologics in cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104621"}}